Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 21Unknown 5Recruiting 5Terminated 4Withdrawn 2Active not recruiting 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 2Genitourinary 2Other hematologic neoplasm 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1

Interventions

pembrolizumab 65Nivolumab 58Magnetic Resonance Spectroscopy 54enzalutamide 39Abiraterone Acetate 37Radiosurgery 36Gemcitabine 35Radiotherapy 33Specimen Handling 32Ipilimumab 32Androgen Antagonists 32Prednisone 31apalutamide 28Cisplatin 28Leuprolide 27Docetaxel 27atezolizumab 26Carboplatin 25durvalumab 23cabozantinib 22darolutamide 20acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 19olaparib 18Goserelin 18Radiation 17Gonadotropin-Releasing Hormone 17gallium 68 PSMA-11 16Biopsy 16Radiotherapy, Intensity-Modulated 15Pluvicto 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Magnetic Resonance Imaging × Genitourinary × Clear all
NCT06116253 2026-05-08

Advanced Diffusion Imaging in Renal Cancer Patients

NYU Langone Health

Phase NA Active not recruiting
39 enrolled
Genitourinary

Kidney Neoplasms

NCT07048613 2025-07-02

Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups

Superior University

Active not recruiting
120 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡